Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer - Wikidata - wikimedia - TriplyDB

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

http://www.wikidata.org/entity/Q33372640

about

Gallbladder Cancer in the 21st Century.Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades EGFR expression in gallbladder carcinoma in North America.Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy Therapeutic options for intrahepatic cholangiocarcinoma Chemotherapy and targeted therapy for gall bladder cancer.Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.Current management of gallbladder carcinoma.The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium.SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas.Targeted therapy for biliary tract cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer.Multidisciplinary collaboration in gallbladder carcinoma treatment: A case report and literature review EGFR and HER2 expression in advanced biliary tract cancer.Genetics of biliary tract cancers and emerging targeted therapies.Emerging pharmacotherapeutic strategies for cholangiocarcinoma.Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.Signaling pathways as therapeutic targets in biliary tract cancer.Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma.An Unusual Presentation of Advanced Intrahepatic Cholangiocarcinoma: When Biopsy Results Fail.[Diagnostics and treatment of cholangiocellular carcinoma].

P2860

Q26784174-861C12E6-9617-428C-BEF1-40A637EC297E Q30234532-A5A5413F-4087-4EDA-8E2F-FD6BDBD4B48D Q30300756-32956879-6B3F-4DC3-86C6-C5B5ACBEF68A Q33372792-E10FEE61-05E0-408F-A0D4-288D6C84AEB9 Q33383423-82AEF5E3-6F16-4DEB-855B-6ABCFDDF3791 Q33391003-45A7B30C-2CF6-4C4E-B9F3-74605B752860 Q33417019-C69C003C-702B-4338-84E5-4709460210F6 Q33621529-7C566C48-FE9F-4CA1-967E-BDC84787BE29 Q33977171-886E73A1-E6D7-400A-830F-09BA3374C1A6 Q33994406-7677D674-F606-4D33-BA78-A41956679B8C Q34650742-5B5EAA18-9D40-4452-B3EE-EC87438618CC Q34982545-7467DC27-6F2E-444E-9F0F-048F609FEE5C Q35583920-7939183B-395A-493A-8BE0-0F23E65E9C14 Q36255706-3B18F809-3982-454C-A5FB-B2FEB7BCF45B Q36376264-CAD4EE9A-DD07-48DE-A547-C3D22E04157A Q36614800-5CEA22A7-8FFC-40DB-AFB3-5C22363130B7 Q36962011-DD66EA90-078A-451B-BAD1-0A4D220C0252 Q37111209-4A03B719-3B79-4E8F-A025-12622602048D Q37132750-7031F09F-AF01-4721-8B61-7E51F21E10BA Q37138732-824A3400-F984-4CEB-9FD5-5AE7CE9F4797 Q37196487-78ED162E-ADAC-413D-9F2F-C2F09DE44F8B Q37288576-B07ED6CE-146B-4995-8C65-1F871B47CD35 Q37362858-09E10A70-3995-47DC-BE4B-E0A1E5494280 Q37765099-53DB62CA-146A-4440-AFAC-52686CF6A196 Q37876403-0CE1D060-D30D-4F77-90A2-007EF143F68C Q37977363-7A6EC056-3DF1-44F1-AE7C-27A2F0E6239A Q37983498-EDE37763-1FE7-45B3-A2FE-35EA555A0DF1 Q38179344-140503A2-3CC2-4048-97E8-A6CC6A3927CE Q38650019-A69DC9B9-9DF7-4F1C-B2DA-5AE850BA3B5B Q38747573-DD61E9E7-2A59-42A9-8B6E-60DFA5F6A321 Q39589946-38047CBD-4859-498D-846C-BF1D63DCB77B Q39662945-4E44AC43-D1A1-42CA-9AFF-8C2988007331 Q47118575-344D2B4F-CF30-4F19-BDF3-7803EFCA54A3 Q47556044-6B513116-A3C8-449D-88AF-6EDA6387ABEE Q51073522-3FAC7113-2A7F-4A4B-9EC8-0298FA112F68

P2860

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

http://www.wikidata.org/entity/Q33372640

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Outpatient chemotherapy with g ...... ents with biliary tract cancer

@ast

Outpatient chemotherapy with g ...... ents with biliary tract cancer

@en

type

label

Outpatient chemotherapy with g ...... ents with biliary tract cancer

@ast

Outpatient chemotherapy with g ...... ents with biliary tract cancer

@en

prefLabel

Outpatient chemotherapy with g ...... ents with biliary tract cancer

@ast

Outpatient chemotherapy with g ...... ents with biliary tract cancer

@en

P1433

Q33372640-18B1D273-5A5E-45CB-A518-40F209F005C5

P1476

Q33372640-743F8772-C864-4BB6-A5DE-DF16868A3FC2

P2093

Q33372640-467F58DB-F836-4322-B64A-4E9B0E2326E1

Q33372640-56748C7E-2BEF-43BB-B5E0-1EE97796CFBC

Q33372640-7035BAC4-FBCD-402E-A501-8E55BE2EA7E6

Q33372640-77463E51-AD70-4C30-ABB0-ABC266AF22B9

Q33372640-86511F90-5354-4EC5-9118-5963DE3B5FEC

Q33372640-8674BB2A-1A8C-4334-89CA-E9216049F510

Q33372640-8A285710-3DA5-43D5-804C-756A740718C4

Q33372640-9F63CF7E-FD4F-4D0C-83D5-E4ADBFA60A67

Q33372640-AC40E0F1-5D63-4149-93AA-8D2C6156656B

P2860

Q33372640-11710EC5-ED56-4680-9144-5FE2BF2303F1

Q33372640-19A87946-BEA7-47A6-A95D-31D8008889B1

Q33372640-2878D81C-0020-4E4F-A5D5-1D1D268DC214

Q33372640-3FF0AD7F-81D1-458A-9D65-C2EA5DB2DAA7

Q33372640-40058E25-C657-4E9B-AB33-0D0EDE1922B5

Q33372640-466BBEAB-CCAA-491B-A77C-0B573CF2029B

Q33372640-486DCD39-8CFB-402E-B1D0-22735EFB09BF

Q33372640-48DFC2FF-36C6-415D-BB4E-FCA5A1039938

Q33372640-4C3728EC-11F9-48D2-A02A-E395F41D31A1

Q33372640-54685749-5026-4976-8B96-ABAAEC651E61

P2888

Q33372640-ED224E4C-00C7-49BD-8829-B48A080003E9

P304

Q33372640-DDB57F48-F9FE-46AF-A613-007CE9FAA025

P31

Q33372640-E1C077BA-8094-4FF5-8FF8-9B6B3FA89500

P356

Q33372640-F937C864-2B5B-4C57-98F4-B221482D9534

P407

Q33372640-77A71088-5035-40F6-8184-3E6978D8D4A7

P433

Q33372640-81AE6E56-4185-4B77-93A7-D703819A6EDA

P478

Q33372640-F61485A9-5CFF-44DE-B96C-6E8B54B6114C

P577

Q33372640-B6B5DC11-8BCE-4BCF-9444-D433650AEB0D

P5875

Q33372640-2F101241-9A06-4009-A299-B2B9F0489C50

P6179

Q33372640-D090FE9C-00BA-4B5F-9A89-855A18E5FA77

P698

Q33372640-48A65906-ADD5-4BF6-9EFB-969258FFB8F2

P921

Q33372640-459BD3FB-2CAB-4458-8D8E-6626476B4788

P932

Q33372640-ED97C44C-495A-4D01-8432-AF9E5CFA399C

P356

P1433

British Journal of Cancer

P1476

Outpatient chemotherapy with g ...... ents with biliary tract cancer

@en

P2093

B Riecken

http://www.w3.org/2001/XMLSchema#string

C Lohrmann

http://www.w3.org/2001/XMLSchema#string

F Otto

http://www.w3.org/2001/XMLSchema#string

H Henss

http://www.w3.org/2001/XMLSchema#string

H Usadel

http://www.w3.org/2001/XMLSchema#string

J Harder

http://www.w3.org/2001/XMLSchema#string

M Geissler

http://www.w3.org/2001/XMLSchema#string

O Kummer

http://www.w3.org/2001/XMLSchema#string

O Opitz

http://www.w3.org/2001/XMLSchema#string

P2860

Worldwide trends in mortality from biliary tract malignancies.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.

Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas.

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

A phase II study of gemcitabine in gallbladder carcinoma.

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma.

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

P2888

P304

848-852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603334

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6822342

http://www.w3.org/2001/XMLSchema#string

P6179

1023151496

http://www.w3.org/2001/XMLSchema#string

P698

16969352

http://www.w3.org/2001/XMLSchema#string

P921

P932

2360533

http://www.w3.org/2001/XMLSchema#string